GlassScriptPhysician profile
Caleb Walter Light
NPI 1881338390
$586.99
in general payments reported to CMS, 2019-2025
8 companies · $564 in 2025
The $564 reported for 2025 was more than what 90% of Registered Nurse providers received nationally (typical 2025 total: $73.55).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $23.47 · 2025: $564.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $587.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $586.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $232.08 | 2024-2025 | Zerbaxa, Pifeltro, Capvaxive |
| Theratechnologies INC. | $81.96 | 2025 | Trogarzo, Egrifta |
| Abbvie INC. | $71.87 | 2025 | |
| Aimmune Therapeutics, INC. | $61.32 | 2025 | Vowst |
| Paratek Pharmaceuticals, INC. | $45.90 | 2025 | Nuzyra |
| Insmed, INC. | $44.35 | 2025 | Brinsupri, Arikayce |
| La Jolla Pharmaceutical Company | $25.94 | 2025 | Xacduro |
| Viiv Healthcare Company | $23.57 | 2025 | Cabenuva |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caleb Light listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.